197 related articles for article (PubMed ID: 15762974)
1. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period.
Tanchev S; Platikanov V; Karadimov D
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):402-3. PubMed ID: 15762974
[No Abstract] [Full Text] [Related]
2. [Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period].
Tanchev S; Platikanov V; Markova S; Slavov N; Bogdanova A; Dimitrova D
Akush Ginekol (Sofiia); 2004; 43(1):16-20. PubMed ID: 15168648
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa in massive postpartum haemorrhage.
Karalapillai D; Popham P
Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
Bouwmeester FW; Jonkhoff AR; Verheijen RH; van Geijn HP
Obstet Gynecol; 2003 Jun; 101(6):1174-6. PubMed ID: 12798521
[TBL] [Abstract][Full Text] [Related]
5. [Case of massive postoperative hemorrhage after hysterectomy and successful application of Novo-Seven].
Velev R; Nenov V; Dacheva R; Vŭtev P
Akush Ginekol (Sofiia); 2006; 45 Suppl 2():19-22. PubMed ID: 16922341
[No Abstract] [Full Text] [Related]
6. [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
Michalska-Krzanowska G
Ginekol Pol; 2010 Jul; 81(7):544-8. PubMed ID: 20825059
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of severe post-partum bleeding after caesarean section using recombinant activated factor VII].
Holub Z; Feyereisl J; Kabelík L; Rittstein T
Ceska Gynekol; 2005 Mar; 70(2):144, 146-8. PubMed ID: 15918270
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
Lim Y; Loo CC; Chia V; Fun W
Int J Gynaecol Obstet; 2004 Nov; 87(2):178-9. PubMed ID: 15491576
[TBL] [Abstract][Full Text] [Related]
9. Acquired hemophilia as a cause of primary postpartum hemorrhage.
Borna S; Hantoushzadeh S
Arch Iran Med; 2007 Jan; 10(1):107-10. PubMed ID: 17198466
[TBL] [Abstract][Full Text] [Related]
10. [Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use].
Courtois L; Becher P; Miot S; Maisonnette-Escot Y; Sautière JL; Berthier F; Samain E; Maillet R; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):78-82. PubMed ID: 17293258
[TBL] [Abstract][Full Text] [Related]
11. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
Veneri D; Franchini M
Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
[No Abstract] [Full Text] [Related]
13. The use of recombinant activated FVII in postpartum hemorrhage.
Franchini M; Franchi M; Bergamini V; Montagnana M; Salvagno GL; Targher G; Lippi G
Clin Obstet Gynecol; 2010 Mar; 53(1):219-27. PubMed ID: 20142658
[TBL] [Abstract][Full Text] [Related]
14. [The use of recombinant factor VIIa on the therapy of massive bleeding after cesarean section].
Uharcek P; Mlyncek M; Kellner M; Lajtman E
Ceska Gynekol; 2007 May; 72(3):200-2. PubMed ID: 17616074
[TBL] [Abstract][Full Text] [Related]
15. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
Matei A; Dolan S; Andrews J; Rivard GÉ
J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
[TBL] [Abstract][Full Text] [Related]
17. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
[No Abstract] [Full Text] [Related]
18. Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII.
Heilmann L; Wild C; Hojnacki B; Pollow K
Clin Appl Thromb Hemost; 2006 Apr; 12(2):227-9. PubMed ID: 16708127
[TBL] [Abstract][Full Text] [Related]
19. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
[TBL] [Abstract][Full Text] [Related]
20. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
